Kati Järvelä
Quick facts
Marketed products
- Prolonged-release oxycodone/naloxone · Pain Management
Oxycodone acts as a mu-opioid receptor agonist for pain relief, while naloxone is an opioid antagonist included to reduce abuse potential by blocking euphoric effects if the formulation is tampered with.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: